The impact of type 2 diabetes and obesity on the long‐term outcomes of more than 85 000 liver transplant recipients in the US

Alimentary Pharmacology and Therapeutics - Tập 40 Số 6 - Trang 686-694 - 2014
Zobair M. Younossi1,2, Maria Stepanova1,2, Sammy Saab3, Shirley Kalwaney1,2, Stephen Clement1, Linda Henry2, Spencer Frost2, Sharon Hunt1,2
1Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA
2Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA
3Department of Medicine David Geffen School of Medicine at the University of California at Los Angeles Los Angeles CA USA

Tóm tắt

SummaryBackgroundType 2 diabetes is known to negatively impact the outcome of chronic liver disease.AimTo evaluate the impact of diabetes on the outcomes of liver transplants (LT).MethodsStudy cohort included adults (>18 years) who received LT in the US between 1994 and 2013 (The Scientific Registry of Transplant Recipients). Pre‐ and post‐transplant diabetes was recorded in patients with mortality follow‐up.ResultsWe included 85 194 liver transplant recipients. Of those, 11.2% had history of pre‐transplant diabetes. The most common indications for liver transplant were hepatitis C (36.4%), alcohol‐related liver disease (20.6%), primary liver malignancy of unspecified aetiology (14.7%), cryptogenic cirrhosis (8.0%), hepatitis B (4.6%) and non‐alcoholic steatohepatitis (3.9%). A total of 96.5% transplants were from deceased donors, and 7.9% donors had history of diabetes. During an average 6.5 years of follow‐up, 31.3% recipients died and 8.8% had a graft failure. In multivariate survival analysis [at least 5 years of cohort follow‐up (N = 35 870)], after adjustment for age, ethnicity, insurance type, history of chronic diseases, HCV infection and noncompliance, independent predictors of recipient mortality included the presence of pre‐transplant diabetes [adjusted hazard ratio (95%CI) = 1.21 (1.12–1.30)] and developing diabetes post‐transplant [1.06 (1.02–1.11)]. Donor's history of diabetes was also independently associated with higher mortality [1.10 (1.02–1.19)]. Furthermore, donor's history of diabetes was also associated with an increased the risk of liver graft failure [1.35 (1.24–1.47)].ConclusionsPresence of type 2 diabetes pre‐ and post‐transplant, as well as presence of type 2 diabetes in the donors, are all associated with an increased risk of adverse post‐transplant outcomes.

Từ khóa


Tài liệu tham khảo

10.1097/SLA.0b013e3182a15db4

10.1038/ncpgasthep0070

10.1053/gast.2003.50016

10.1016/j.transproceed.2008.05.072

10.1053/j.gastro.2004.09.040

10.1136/gut.2010.213553

10.1007/s10620-010-1267-5

10.1097/00007890-199611150-00011

10.1097/MOG.0b013e3283457d5d

2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999–2008. U.S. Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau Division of Transplantation Rockville MD 2010.

10.1016/j.cgh.2011.03.020

10.1097/01.TP.0000158877.74629.AA

10.1111/j.1600-6143.2006.01242.x

10.1097/SLA.0000000000000265

10.1016/j.transproceed.2013.06.001

10.1002/lt.21699

10.1002/lt.20439

10.2174/157339913804143234

10.3748/wjg.v18.i28.3627

10.1002/lt.23818

10.1016/j.transproceed.2012.11.009

10.1097/TP.0b013e318238dacd

10.1002/lt.21866

10.1136/bmjopen-2013-003287

10.1016/j.jhep.2011.01.040

10.1097/01.tp.0000250936.73034.98

10.1111/j.1600-6143.2006.01243.x

10.1111/j.1600-6143.2010.03293.x

10.4240/wjgs.v3.i11.167

10.2337/diabetes.50.8.1844

10.1111/j.1365-2036.2006.03112.x

10.1111/apt.12084

10.1111/apt.12543

Thông tin
Thông tin xuất bản

Alimentary Pharmacology and Therapeutics

Tập 40 Số 6

686-694

Thông tin tác giả